Back to User profile » Dr Henrik Watz
Papers published by Dr Henrik Watz:
Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET
Alter P, Stoleriu C, Kahnert K, Henke MO, Bals R, Trudzinski FC, Watz H, Speicher T, Söhler S, Welte T, Rabe KF, Wouters EFM, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2911-2923
Published Date: 6 December 2023
Estimating the Health and Economic Impact of Improved Management in Prevalent Chronic Obstructive Pulmonary Disease Populations in England, Germany, Canada, and Japan: A Modelling Study
Adams EJ, van Doornewaard A, Ma Y, Ahmed N, Cheng MK, Watz H, Ichinose M, Wilkinson T, Bhutani M, Licskai CJ, Turner KME
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2127-2146
Published Date: 27 September 2023
Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study
Mahler DA, Watz H, Emerson-Stadler R, Ritz J, Gardev A, Shaikh A, Drummond MB
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1729-1740
Published Date: 10 August 2023
Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
Alter P, Kahnert K, Trudzinski FC, Bals R, Watz H, Speicher T, Söhler S, Andreas S, Welte T, Rabe KF, Wouters EFM, Sassmann-Schweda A, Wirtz H, Ficker JH, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1703-1713
Published Date: 29 July 2022
Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET
Fischer C, Jörres RA, Alter P, Trudzinski FC, Yildirim, Bals R, Vogelmeier CF, Kauffmann-Guerrero D, Behr J, Watz H, Holle R, Kahnert K
Patient Preference and Adherence 2022, 16:1759-1770
Published Date: 26 July 2022
Qualitative Validation of COPD Evidenced Care Pathways in Japan, Canada, England, and Germany: Common Barriers to Optimal COPD Care
Meiwald A, Gara-Adams R, Rowlandson A, Ma Y, Watz H, Ichinose M, Scullion J, Wilkinson T, Bhutani M, Weston G, Adams EJ
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1507-1521
Published Date: 1 July 2022
Association of Airway Eosinophilia with Small Airway Dysfunction in Patients with Mild and at Risk for COPD
Abdo M, Pedersen F, Trinkmann F, Herth FJF, Rabe KF, Kirsten AM, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1403-1408
Published Date: 17 June 2022
Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study
Koopman M, Franssen FME, Gaffron S, Watz H, Troosters T, Garcia-Aymerich J, Paggiaro P, Molins E, Moya M, van Burk L, Maier D, Garcia Gil E, Wouters EFM, Vanfleteren LEGW, Spruit MA
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:517-533
Published Date: 8 March 2022
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
Kahnert K, Jörres RA, Lucke T, Trudzinski FC, Mertsch P, Bickert C, Ficker JH, Behr J, Bals R, Watz H, Welte T, Vogelmeier CF, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3189-3199
Published Date: 24 November 2021
TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow
Mahler DA, Ludwig-Sengpiel A, Ferguson GT, de la Hoz A, Ritz J, Shaikh A, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2455-2465
Published Date: 28 August 2021
The Relevance of Small Airway Dysfunction in Asthma with Nocturnal Symptoms
Abdo M, Trinkmann F, Kirsten AM, Biller H, Pedersen F, Waschki B, Von Mutius E, Kopp M, Hansen G, Rabe KF, Bahmer T, Watz H
Journal of Asthma and Allergy 2021, 14:897-905
Published Date: 13 July 2021
Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
Lutter JI, Jörres RA, Trudzinski FC, Alter P, Kellerer C, Watz H, Welte T, Bals R, Kauffmann-Guerrero D, Behr J, Holle R, Vogelmeier CF, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:987-998
Published Date: 14 April 2021
Persistent Uncontrolled Asthma: Long-Term Impact on Physical Activity and Body Composition
Abdo M, Waschki B, Kirsten AM, Trinkmann F, Biller H, Herzmann C, von Mutius E, Kopp M, Hansen G, Rabe KF, Bahmer T, Watz H
Journal of Asthma and Allergy 2021, 14:229-240
Published Date: 12 March 2021
Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant
Pedersen F, Trinkmann F, Abdo M, Kirsten AM, Rabe KF, Watz H, Baraldo S, Saetta M, Hohlfeld JM, Holz O
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:487-493
Published Date: 1 March 2021
Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus
Ramakrishnan S, Janssens W, Burgel PR, Contoli M, Franssen FME, Greening NJ, Greulich T, Gyselinck I, Halner A, Huerta A, Morgan RL, Quint JK, Vanfleteren LEGW, Vermeersch K, Watz H, Bafadhel M
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:321-332
Published Date: 16 February 2021
Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
Ferguson GT, Shaikh A, Tetzlaff K, Mueller A, Magnussen H, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2879-2888
Published Date: 11 November 2020
Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
Lutter JI, Jörres RA, Welte T, Watz H, Waschki B, Alter P, Trudzinski FC, Ohlander J, Behr J, Bals R, Studnicka M, Holle R, Vogelmeier CF, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2787-2798
Published Date: 5 November 2020
Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis
Watz H, Rickard K, Rheault T, Bengtsson T, Singh D
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2199-2206
Published Date: 16 September 2020
Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K
Patient Preference and Adherence 2019, 13:1711-1721
Published Date: 10 October 2019
Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
Alter P, Mayerhofer BA, Kahnert K, Watz H, Waschki B, Andreas S, Biertz F, Bals R, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2163-2172
Published Date: 20 September 2019
AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
Sethi S, Kerwin E, Watz H, Ferguson GT, Mroz RM, Segarra R, Molins E, Jarreta D, Garcia Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:667-682
Published Date: 22 March 2019
Rating sputum cell quality in clinical trials for asthma and COPD treatment
Pedersen F, Zissler UM, Watz H, Rabe KF, Hohlfeld JM, Holz O
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:195-198
Published Date: 8 January 2019
Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
Greulich T, Mager S, Lucke T, Koczulla AR, Bals R, Fähndrich S, Jörres RA, Alter P, Kirsten A, Vogelmeier CF, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2999-3002
Published Date: 28 September 2018
Identification of novel target genes in human lung tissue involved in chronic obstructive pulmonary disease
Heinbockel L, Marwitz S, Schromm AB, Watz H, Kugler C, Ammerpohl O, Schnepf K, Rabe KF, Droemann D, Goldmann T
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2255-2259
Published Date: 26 July 2018
Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD
Watz H, Bagul N, Rabe KF, Rennard S, Alagappan VKT, Román J, Facius A, Calverley PMA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:813-822
Published Date: 6 March 2018
ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD
Watz H, Troosters T, Beeh KM, Garcia-Aymerich J, Paggiaro P, Molins E, Notari M, Zapata A, Jarreta D, Garcia Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2545-2558
Published Date: 24 August 2017
Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:981-987
Published Date: 22 March 2017
Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease
Rodriguez-Roisin R, Tetzlaff K, Watz H, Wouters EF, Disse B, Finnigan H, Magnussen H, Calverley PM
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1973-1981
Published Date: 22 August 2016
COPD: the patient perspective
Jones PW, Watz H, Wouters EFM, Cazzola M
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:13-20
Published Date: 19 February 2016
Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD
Holz O, Roepcke S, Watz H, Tegtbur U, Lahu G, Hohlfeld JM
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1393-1402
Published Date: 21 July 2015